基本信息
views: 20

Bio
With a double degree in Medicine and Pharmacy Harald Schmidt is an international leader in drug discovery and therapy as well as big data for network medicine. He performs high risk/high potential benefit research in areas of major medical need. His multi-national leadership experience in Academia and Industry has led to excellent scientific achievements (Hirsch-index 87) with high socio-economic impact such as patents and biotech spin-offs. He is a successful entrepreneur, dedicated teacher and team leader and through Rotary International highly engaged in his community.
Harald Schmidt is an MD and pharmacist and has worked in three continents, Europe, USA and Australia in leadership positions both in academia, biotech and industry. His work focusses on drug discovery and repurposing, target validation, biomarkers within the context of personalised and precision medicine. He also founded two biotech companies, one with a drug in late phase III clinical development. He is co-editor in chief of Systems Medicine.
Harald Schmidt is an MD and pharmacist and has worked in three continents, Europe, USA and Australia in leadership positions both in academia, biotech and industry. His work focusses on drug discovery and repurposing, target validation, biomarkers within the context of personalised and precision medicine. He also founded two biotech companies, one with a drug in late phase III clinical development. He is co-editor in chief of Systems Medicine.
Research Interests
Papers共 479 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Moritz Lehners,Hannes Schmidt, Maria T. K. Zaldivia,Daniel Stehle, Michael Krämer,Andreas Peter,Julia Adler,Robert Lukowski,Susanne Feil,Robert Feil
Nature Communicationsno. 1 (2025): 1-21
Characterization of CNP-induced cGMP signaling in the murine hippocampus (2024)
Ana I Casas,Rebecca D Szepanowski, Sebastian E Vonhof, Svenja Rohde, Lucas Schöfl,Harald HHW Schmidt,Christoph Kleinschnitz
Network-based therapeutic approach for brain ischemia A broad therapy for a specific patient (2024)
Rene Weyer, Anna-Lena Friedrich, Eva Lessmann,Lisa Krebes,Ali Khadim,Elie El-Agha, Clemens Rupert, Andreas Günther,Hannes Schmidt,Michaela Kuhn,Swati Dabral
C-type natriuretic peptide - Guanylyl cyclase B effects in Pulmonary Fibrosis (2024)
Prashant Changoer, Zeinab Mamdouh,Christian Grätz,Ana Casas,Martin Jaeger, Robert Loewe,Harald Schmidt,Romana Netea-Maier
Targeting Signalling Modules in Thyroid Cancer (2024)
Mahmoud H. Elbatreek,Ruma Banerjee,Alexandra Petraina,Victor Vitvitsky, Thomas P. Burris,Vu Thao-Vi Dao,Stefan H. Heinemann,Toshinori Hoshi,Mahdi Jamili,Thomas Koelblen,Theodora Saridaki,Roland Schönherr,Wolfgang Sippl,Csaba Szabo,Yutao Tian,Aurore Valfort,Tianyuan Wang,Li Zhang,Karim Zuhra,Harald H. H. W. Schmidt
Extending apo-sGC to haem-sensing proteins and a landscape of haem mimetic pharmacophores with broad applications (2024)
Liana Lisboa Fernandez, André Luiz Rodrigues Palmeira,Mayra Pacheco Pachado, Tiago Franco de Oliveira, Leonardo Martins de Paula, Carolina Fontela,Alexandra Petraina,Theodora Saridaki,Cristian Nogales,Ana I. Casas,Harald H. H. W. Schmidt
XIV RPDApp.1-1, (2024)
Fernando M. Delgado-Chaves, Lisa Spindler, Farzaneh Firoozbakht,Andreas Maier,Michael Hartung,Olga Tsoy,Quirin Manz,Johannes Kersting,Judith Bernett,Rui-Sheng Wang,Joseph Loscalzo, Julia Guthrie,Jörg Menche, Robert P. Loewe, Francesco Sirci, Montserrat Puiggros,Emre Guney, Zina Piper,Harald H. H. W. Schmidt,Markus List,Jan Baumbach
Drug Repurposingno. 2 (2024)
NOS recoupling with L-citrulline, folate, and vericiguat in a NOX5-positive subgroup of HFpEF patients A Phase IIa proof-of-concept trial (2024)
crossref(2023)
Load More
Author Statistics
#Papers: 481
#Citation: 32695
H-Index: 94
G-Index: 177
Sociability: 8
Diversity: 4
Activity: 18
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn